Skip to main content

Table 2 Comparison of effects of the two types of surfactants on complications among neonates

From: Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates

Variables

Type of surfactant

RR (95% CI)

Beraksurf

BLES

P value

PDA (%)

    

No

29 (45.3)

25 (39.1)

0.474

0.89 (0.66–1.20)

Yes

35 (54.7)

39 (60.9)

IVH (%)

    

No

59 (92.2)

57 (89.1)

0.544

0.71 (0.23–2.13)

Yes

5 (7.8)

7 (10.9)

Sepsis (%)

    

No

60 (93.8)

55 (85.9)

0.143

0.44 (0.14–1.36)

Yes

4 (6.3)

9 (14.1)

Pneumothorax (%)

   

No

59 (92.2)

50 (78.1)

0.025

0.35 (0.13–0.93)

Yes

5 (7.8)

14 (21.9)

Pulmonary hemorrhage (%)

   

No

59 (92.2)

49 (76.6)

0.015

0.33 (0.12–0.86)

Yes

5 (7.8)

15 (23.4)

Mortality (%)

    

No

53 (82.8)

44 (68.8)

0.063

0.55 (0.28–1.05)

Yes

11 (17.2)

20 (31.3)

  1. * P value was calculated using chi−2 statistics at 95% level of confidence interval
  2. RR: risk ratio, PDA: patent ductus arteriosus, IVH: intraventricular hemorrhage